Sprintex Limited
AASX:SIX0.06
AUD
+0.00
(+7.84%)
ISIN
AU000000SIX0
Return %
Stock
S&P 500
1Y
10.00
14.20
3Y
266.67
81.12
5Y
-26.67
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- Jay Upton
- Full Time Employees
- 20
- Sector
- Producer manufacturing
- Industry
- Auto parts: OEM
- Address
- 283 Rokeby Road Subiaco WA Australia 6009
- IPO Date
- Mar 28, 2008
- Website
- sprintex.com.au
- Similar Companies
- Business
- Sprintex Limited (ASX:SIX) designs, manufactures, and sells miniature linear and rotary actuators, micro pumps, and precision valves for medical, industrial, aerospace, and defense applications. Its core products include the S series linear actuators for high-force, compact motion control; the SA series for medical infusion pumps and ventilators; rotary actuators like the P series for valve control; micro diaphragm pumps for fuel cells and life support systems; and precision solenoid valves for fluid management; all offered under brands such as LeeSprintex for integrated solutions. The company, founded in 2017 and headquartered in Bayswater, Australia, operates primarily in Australia with distribution networks across North America, Europe, and Asia, targeting OEMs in healthcare devices, unmanned systems, and portable instrumentation. In recent developments, Sprintex expanded its product portfolio with new high-performance micro pumps launched in 2024 for hydrogen fuel cell applications and formed a strategic distribution partnership with a major U.S. aerospace supplier in early 2025 to accelerate penetration into defense markets. Additionally, the company secured a A$2.5 million funding facility in late 2024 to support production scaling and completed the acquisition of key intellectual property assets from a European actuator specialist in mid-2025, enhancing its rotary motion technology offerings. These moves position Sprintex for growth in emerging sectors like sustainable energy and advanced medical diagnostics.